Stock Analysis
Teleflex Incorporated (TFX) Stock Analysis
Teleflex Incorporated (TFX) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Teleflex Incorporated (TFX) currently has an AIQ Score of 47/100, indicating a neutral setup. Risk is the strongest factor at 64/100. Momentum is the weakest current factor at 29/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
TFX at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $130.99 |
| AIQ Score | 47/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $6.22B |
| P/E Ratio | 16.05 |
| Forward P/E | — |
| EPS | $2.29 |
| Revenue TTM | $570.33M |
| Dividend Yield | 0.00% |
| Beta | 0.81 |
| Volume | 574.86K |
| 52-week range | $100.18-$145.00 |
| RSI 14 | 31.54 |
| 50-Day SMA | $135.62 |
| 200-Day SMA | $123.67 |
| Analyst Price Target | $152.18 |
| Next Earnings | Nov 5, 2026 |
TFX
OverviewTFX Stock Analysis Summary
Teleflex Incorporated (TFX) currently has an AIQ Score of 47/100, indicating a neutral setup. Risk resilience is the strongest factor at 64/100. Momentum is the weakest current factor at 29/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, TFX has AIQ Score of 47/100 with Risk resilience base of 64/100 and fading Momentum at 29/100. Wait for component alignment before adding exposure.
Risk resilience (64/100) leads while Momentum (29/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.77% stock move · TFX classified in Medical - Instruments & Supplies.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is TFX Bullish or Bearish Right Now?
TFX currently has a neutral overall setup. Risk Resilience is the strongest factor at 64/100, while Momentum is weakest at 29/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Risk Resilience is supportive at 64/100.
- - Analyst target implies +16.18% upside from the latest quote.
- - Momentum is weak at 29/100.
- - Technical consensus has more sell votes than buy votes (35 vs 8).
Current Consensus
TFX's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 2 neutral, and 35 sell votes. TFX's 14-day RSI is 31.54, which places the stock in a weaker momentum range. TFX's beta is 0.81, indicating market sensitivity broadly in line with the market.
What Changed in TFX?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the TFX Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
TFX Decision Framework
Public evidence layers, setup checks, and risk context for Teleflex Incorporated.
Teleflex Incorporated (TFX) Stock Analysis
Teleflex Incorporated has an AIQ Score of 47/100 in a Neutral regime. Risk is strongest at 64/100. Beta is 0.81, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | TFX is in a Neutral AIQ regime with score 47/100. |
| Signal Conflict | The primary conflict is that risk leads at 64/100 while momentum lags at 29/100. |
| Factor Evidence | Momentum 29/100 · Value 62/100 · Quality 39/100 · Risk 64/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 64/100.
Momentum is 29/100 and RSI (14) is 31.5.
TFX is in a Neutral regime at 47/100.
Risk factor is 64/100 with beta 0.81 and annual volatility 40.39%.
Current conflict: risk leads at 64/100 while momentum lags at 29/100.
TFX Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
TFX Fundamentals
TFX valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
TFX Technical Analysis
TFX technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
TFX Stock Catalysts
Track TFX earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
TFX Dividend Analysis
TFX dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
TFX Financial Data
TFX revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
TFX Risk Analysis
TFX volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
TFX Stock News
TFX stock news, market tone, recent headlines, and catalyst context.
TFX vs Medical Devices Peers
Current peer cohort: TFX · TMDX · VTRS · WAT · XRAY. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| TFX Current stock | 47/100 | 62/100 | 29/100 | 64/100 | 0.12 | 40.39% | Current |
| TMDX TransMedics | 42/100 | 32/100 | 34/100 | 33/100 | -0.25 | 57.57% | TFX vs TMDX |
| VTRS Viatris | 54/100 | 73/100 | 51/100 | 64/100 | 1.53 | 32.17% | TFX vs VTRS |
| WAT Waters Corporation | 47/100 | 32/100 | 52/100 | 65/100 | 1 | 36.07% | TFX vs WAT |
| XRAY Dentsply Sirona | 46/100 | 73/100 | 34/100 | 51/100 | -0.44 | 46.33% | TFX vs XRAY |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts6 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching TFX
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for TFX
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
TFX Stock FAQ
What is TFX stock price today?
Teleflex Incorporated's current stock price is $130.99. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is TFX bullish or bearish right now?
TFX's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is TFX's market cap?
TFX's market cap is $6.22B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is TFX's current P/E ratio?
TFX's current P/E ratio is 16.05 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is TFX's RSI?
TFX's 14-day RSI is 31.54 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is TFX above its 50-day and 200-day moving averages?
TFX is -3.41% from its 50-day SMA and 5.92% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is TFX's next earnings date?
TFX's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does TFX pay a dividend?
TFX's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.